Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lydia Jasmin Duerner"'
Autor:
Jens Fischer, Tina Weinzierl, Christian Klein, Hofer Thomas U, Werner Scheuer, Christian Gerdes, Claudio Sustmann, Mi He, Lydia Jasmin Duerner, Marina Bacac, Ralf Hosse, Inja Waldhauer, Pablo Umana, Karlheinz Zick, Ekkehard Moessner
Publikováno v:
Cancer Research. 76:2955-2955
Introduction: Trastuzumab and pertuzumab are humanized antibodies recognizing different functional HER2 epitopes. Preclinical data demonstrated strong anti-tumoral efficacy when combining them (Scheuer et al., Canc Res, 2009). The CLEOPATRA trial sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ec7ec81dd44603c08270b308914cc2
https://doi.org/10.1158/1538-7445.am2016-2955
https://doi.org/10.1158/1538-7445.am2016-2955
Autor:
Pablo Umana, Ralf Hosse, Remo Lüoend, Melanie Latzko, Klaus Strein, Anne Freimoser-Grundschober, Reto Gianotti, Jörg Zielonka, Ramona Murr, Ekkehard Mössner, Christian Klein, Tea Rodriguez Diaz, Chloé Friang, Marina Bacac, Lydia Jasmin Duerner, Oliver Ast, Tanja Fauti, Camille Delon, Samuel Moser, Minh Diem Vu, Peter Bruenker, Erwin van Puijenbroek, Tina Weinzierl
Publikováno v:
Blood. 126:2998-2998
Background & Aim: T-cell bispecific antibodies (TCBs) binding to a target on tumor cells and CD3 on T cells induce potent T-cell mediated killing of cells carrying the target. In contrast to targets like e.g. CD38 or CD138, B-cell maturation antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83d0c28c975fbab84dd30f070e874188
https://doi.org/10.1182/blood.v126.23.2998.2998
https://doi.org/10.1182/blood.v126.23.2998.2998